In CLL cells miR-150 targeted forkhead box P1 (FOXP1) and GRB2-associated binding protein 1 (GAB1), thereby reducing B-cell receptor signaling [13]. Here, GAB1 is linked to B-cell chronic lymphocytic leukemia.